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Abstract
Introduction—Behavioral couples therapy (BCT) has been found to improve long-term 
abstinence rates in alcohol- and substance-dependent populations but has not been tested for 
smoking cessation. This pilot study examined the feasibility and acceptability of BCT for 
smoking-discordant couples.
Methods—Forty-nine smokers (smoking >10 cigarettes/day) with non-smoking partners were 
randomized to receive a couples social support (BCT-S) intervention, or an individually-delivered 
smoking cessation (ST) treatment. The couples were married or cohabiting for at least one year, 
with partners who had never smoked or had not used tobacco in one year. Both treatments 
included seven weekly sessions and 8-weeks of nicotine replacement therapy. Participants were 
followed for six months post-treatment. The Partner Interaction Questionnaire (PIQ) was used to 
measure perceived smoking-specific partner support.
Results—Participants were 67% male and 88% White. Biochemically-verified cessation rates 
were 40.9%, 50% and 45% in BCT-S, and 59.1%, 50%, and 55% in ST, at end of treatment, 3-, 
and 6-months, respectively, and did not differ significantly between treatment conditions at any 
time point (all p’s > .05). Perceived smoking-specific partner support at post-treatment did not 
significantly differ between treatment groups (M=2.45, SD .81 in BCT-S; M=2.27, SD .92 in ST; 
t(38) = .67, p = .51).
Conclusions—Results of this pilot study do not provide support for the efficacy of BCT in 
smoking discordant couples.
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INTRODUCTION
Cigarette smoking is a leading cause of preventable death and smoking-related disability 
(USDHHS, 2010). For the nearly 25 million non-smokers married to smokers, second-hand 
smoke exposure is associated with a 35% greater risk of lung cancer for the non-smoking 
partner (Crispo et al., 2004; Fiore, 2008; USDHHS, 2004). For children, exposure to second-
hand smoke has been found to be associated with middle ear infections, respiratory tract 
infections, and 1 million cases of asthma annually (CDC, 2008). Therefore, effective 
smoking cessation treatments can have considerable public health impact for smokers, their 
partners, and their families. Although smoking rates in the U.S. have declined since 2005 to 
approximately 18.1%, little change has been noted since 2012 indicating a plateau in 
cessation rates (CDC, 2014). Even among those who quit successfully, relapse often occurs 
within 5 months following the quit attempt (USDHHS, 2000). Continued improvement in 
treatments are needed that build upon current best practices and incorporate advances in 
substance abuse treatment models to increase long-term abstinence rates (Piasecki & Baker, 
2001).
The characteristics of a smoker’s social network may enhance efforts to quit smoking 
leading to an improved likelihood of long-term abstinence. Perceived social support 
facilitates attempts to quit smoking (Albertsen, Borg, & Oldenburg, 2006; May, West, 
Hajek, McEwen, & McRobbie, 2007; Vilchinsky, et al., 2011), and partner support has 
predicted greater readiness to quit smoking (Rayens, Hahn, & Hedgecock, 2008), an 
increased likelihood of quitting (Coppotelli & Orleans, 1985; Mermelstein, et al., 1986; 
Pollack, et al., 2006; Rayens, Hahn, & Nicholson, 2011) and a lower likelihood of relapse 
after quitting (Gulliver et al., 1995; Mermelstein, Lichtenstein, & McIntyre, 1983; Pollak & 
Mullen, 1997).
Social support from a romantic partner has been found to be particularly influential in 
smoking cessation attempts. Simply having a partner, as opposed to being single, leads to a 
higher likelihood of abstinence after a smoking cessation intervention (Brothers & Borrelli, 
2011). In a recent longitudinal study of couples in which one or both partners smoked, 
higher perceived partner responsiveness at baseline predicted a decreased likelihood of 
smoking and fewer cigarettes smoked per day nine years later (Derrick, Leonard, & Homish, 
2013). Smokers who are confident in their ability to work with their partner as a team in a 
smoking cessation effort are more likely to successfully quit (Sterba, et al., 2011), and there 
is evidence that partners of smokers are interested in helping their partners quit (Thomas, et 
al., 2009). Positive partner support for quitting smoking has been related to higher 
engagement in smoking cessation treatment (Richardson et al., 2013). Interventions that 
explicitly promote romantic partner support may improve long-term abstinence rates in 
smokers attempting to quit.
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Previous smoking cessation studies that included a component to enhance partner support 
have had limitations and did not demonstrate evidence of improved quit rates (Park, 
Tudiver, & Campbell, 2012). Various interventions were utilized, however, results 
suggested that some of the interventions failed to increase perceived social support (Park, 
Tudiver, & Campbell, 2012). Past studies often utilized a wide definition of partner that 
included co-workers and friends, in addition to spouses and live-in partners. In an earlier 
review, Park (2004) found that studies that included solely married or live-in partners 
produced higher odds ratios of cessation compared with other trials. Because romantic 
cohabitating partners have greater proximity to the smoker, they may be better able to 
provide consistent smoking-specific support behaviors over time than more distal partners 
(May & West, 2000). Additional limitations of previous studies included a lack of 
biochemical verification of cessation, non-randomized designs, lack of adequate control 
groups, and the lack of a theoretical framework to guide the study (May & West, 2000; Park 
et al., 2012; Westmaas, 2010).
Behavioral couples’ therapy (BCT), an empirically developed intervention, is recognized as 
an efficacious method for the treatment of alcohol and other substance use disorders (SUD; 
Epstein, E.E., & McCrady, B.S. (2002); Epstein, E.E., McCrady, B.S., Morgan, T.J., Cook, 
S.M., Kugler, G., & Ziedonis, D., 2007a; Powers, Vedel & Emmelkamp, 2008). BCT has 
well-specified treatment components involving partners who do not have substance abuse or 
dependence issues, and may be ideal for smoking cessation. BCT offers a partner-involved 
approach designed to focus not only on the addictive behavior, but also on the partner’s role 
in supporting abstinence and on the relational support factors conducive to long-term 
abstinence (O’Farrell & Schein, 2011). Across studies of SUD, BCT has demonstrated 
significantly greater abstinence up to two years post-treatment compared to individual-
focused approaches (O’Farrell & Clements, 2012). BCT has also demonstrated efficacy in 
improving relationship functioning, increasing session attendance, and promoting greater 
treatment retention compared to individual-only modalities (O’Farrell, Murphy, Alter & 
Fals-Stewart, 2010; Stanton & Shadish, 1997; Powers et al, 2008). To date, no known 
studies have adapted and applied BCT to cohabitating couples in which one partner smokes. 
The purpose of this pilot randomized clinical trial was to examine the feasibility and 
acceptability of BCT for smoking cessation in smoking-discordant cohabitating couples. We 
also wanted to compare smoking cessation outcomes among smokers who were randomized 
to receive either BCT or an individual cessation treatment (ST), with a non-smoking 
significant other. Based on previous research with BCT for alcohol and other SUD (Meis et 
al., 2013), we hypothesized that smokers who participated in a BCT intervention would 
demonstrate higher point-prevalence abstinence at end of treatment, 3-month, and 6-month 
follow-ups.
METHODS
Participants
Participants were 49 current smokers who wanted help quitting smoking and their non-
smoking partners. To be included, participants had to be: a) at least 18 years of age, b) 
smoking at least 10 cigarettes per day for at least one year; c) in a heterosexual marriage or 
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cohabiting romantic relationship for more than one year; and, d) willing to use and have no 
contraindications for transdermal nicotine patch (TNP). Partners of eligible smokers had to 
be at least 18 years of age, nonsmokers (or not used tobacco in the previous one year), 
willing to participate in the study, and have an expired carbon monoxide (CO) level at 
baseline < 10 parts per million. Potential participants were excluded at baseline if they were: 
a) currently pregnant or nursing; b) using smokeless or other forms of tobacco; c) in a 
severely distressed romantic relationship or marriage (defined as 1.5 SD below Dyadic 
Adjustment Scale score [DAS] mean or DAS < 60; Spanier, 1976), or have a history of 
physical domestic violence by their partner (by self or partner report) in the prior year; d) 
currently using other pharmacotherapies for smoking cessation, or e) diagnosed with a 
psychiatric disorder, taking prescribed psychotropic medication, or receiving psychotherapy. 
Two items from the Alcohol Use Disorders Identification Test (AUDIT) were used to screen 
out those participants who were drinking alcohol at problematic levels of use (Saunders, et 
al., 1993). Potential participants were asked: How often do you have a drink containing 
alcohol? (never; less than monthly; monthly; weekly; daily or almost daily); How many 
drinks containing alcohol do you have on a typical day when you are drinking? (1–2; 3–4; 
5–6; 7–9; 10 or more). We excluded only persons who engaged in binge drinking or heavy 
drinking on a regular basis. The National Jewish Health Institutional Review Board 
approved the study and all participants provided written informed consent to participate.
Procedure
Participants were recruited from the community via newspaper and television 
advertisements for cigarette smokers who wanted to quit and were living with a non-
smoking partner who was interested in assisting with the cessation effort. Individuals who 
responded to advertisements completed a brief telephone screen to determine initial 
eligibility prior to scheduling a baseline session. Potential participants were asked their age, 
relationship status, current smoking level and other tobacco use, estimate of partner’s 
smoking and/or tobacco use, current medications prescribed, any diagnosed medical 
conditions, and recent hospitalizations. If deemed potentially eligible, participants (smokers) 
and their partners were invited to a baseline assessment interview to confirm study 
eligibility. At that time, the Psychiatric Diagnostic Screening Questionnaire (PDSQ) was 
administered to smokers and their partners to exclude individuals that met criteria for current 
mood, anxiety, substance dependence, psychotic or somatoform disorders (Zimmerman & 
Mattia, 2001). The baseline consent and assessment session lasted approximately 40–50 
minutes. See Figure 1 for a diagram of participant flow.
Randomization
At baseline, participants were randomly assigned to receive either a couples’ social support 
smoking cessation intervention (BCT-S), or an individually-delivered behavioral therapy 
smoking cessation treatment (ST). An urn randomization procedure (Stout, Wirtz, 
Carbonari, & DelBoca, 1994; Wei, & Lachin, 1978) was used to probabilistically balance 
the experimental and control groups on three potential prognostic factors: 1) gender of the 
smoker; 2) nicotine dependence severity assessed by time to first cigarette of the day [<30 
minutes after waking, versus >30 minutes]; and 3) relationship happiness on the Dyadic 
Adjustment Scale (using a 7-point Likert item: >3.5 (“happy or better”) by both members of 
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the couple versus <3.5 (“less than happy”) by one or both partners. Twenty-six participants 
were randomized to BCT-S and 23 were randomized to ST.
Assessments
Following consent and randomization, participants were informed of their treatment 
assignment. All couples attended the baseline assessment together; however, they completed 
baseline assessments, such as the DAS, separately. In the treatment sessions that followed, 
participants attended as couples in BCT-S only. Participants completed assessments at each 
treatment session and at 3- and 6-months post-treatment. Both treatment conditions included 
seven weekly, 60-minute sessions and 8-weeks of transdermal nicotine replacement therapy.
Treatments
Across both BCT-S and ST, treatments were conducted according to specific manuals, and 
were administered by five therapists (a licensed psychologist, a master’s level clinician, an 
intern, and two bachelor’s level therapists) trained in BCT-S and ST protocols. All therapists 
delivered both BCT-S and ST treatments. The session number, duration, and therapist 
contact time were matched across conditions. Participants in both conditions received 
behavioral strategies to assist with smoking cessation based on the most current clinical 
guidelines during the time that the intervention was completed (USDHHS, 2000). The initial 
treatment manual for BCT-S was written using an adaption of the empirically supported 
techniques and the clinical approach specified by BCT (O’Farrell & Fals-Stewart, 2006). 
The preliminary manual was piloted with five smoking-discordant couples prior to initiation 
of this study. An iterative treatment development process was conducted in which 
participants completed brief questionnaires in which they rated session utility, helpfulness, 
participant motivation, and compliance. Open-ended questions also assessed treatment 
utility and acceptability of treatment sessions and exercises. Sessions were audiotaped and 
reviewed by the investigative team to assess the utility, feasibility, and acceptability of the 
BCT-S treatment components and procedures. Session content for each treatment condition 
is detailed in Table 1.
Two treatment sessions were held prior to the assigned quit date (during the first week of 
study participation) and the quit date occurred at session 3 for both treatment conditions. We 
“front-loaded” the treatment schedule during the first few days after the quit attempt - 
sessions four and five occurred 3 days and 7 days after the quit date, respectively. Session 6 
occurred one week later (at 14 days post-quit) and the final session (session 7) occurred 28 
days post-quit. Participants were then followed for 6 months post-treatment.
Behavioral Couples Therapy - Smoking (BCT-S)—Participants were provided a 
BCT-S Couples Workbook that provided an overview of the treatment approach, session 
format, and all handouts. Motivation for smoking cessation for both the smoker and partner 
was discussed. The couples completed an I Quit Contract in which the smoker and the 
partner signed a written agreement detailing their commitment to quitting. Daily I Quit 
Discussion exercises designed to support the quit attempt were introduced. The couple was 
asked to role-play during the session, to specify a time each day to perform the I Quit 
Discussion, and to record the exercise on their study calendar. The smokers were asked to 
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identify strategies that contributed to past successes and relapses and partners were asked 
about their experiences of either quitting (if a former smoker) or expectations of quitting (if 
never smoked).
Each couple completed a High Risk Situations Worksheet in which the smoker identified 
situations that could jeopardize abstinence. The smoker was asked to problem-solve ways to 
avoid, alter, or use substitutes for cigarettes to cope with the situation and partners were 
encouraged to offer solutions and helpful support behaviors. The couple agreed on a specific 
time within 24-hours prior to the assigned quit day to complete the Prepare A Non-Smoking 
Home exercise. This included discarding all tobacco products and cleaning smoking areas to 
minimize triggers and smoking cues. Couples were asked to complete a Catch Your Partner 
Doing Something Nice exercise, which involved surprising one another with praise and/or 
acknowledgment and they were encouraged to continue this exercise through the week. At 
subsequent sessions, the therapist congratulated smokers on their success and the couples for 
their ability to work as a team to achieve the abstinence goal.
The couple was instructed in common withdrawal symptoms and the importance of effective 
coping via the Support Strategies handout. The couple was asked to: consider behaviors that 
provided positive support (encouragement) and/or negative support (reminding, 
questioning); create a menu of support behaviors tailored to reinforce the smoker’s efforts to 
quit; and consider how they used support behaviors over the prior weeks. Both positive and 
negative support behaviors were identified and respective utility was discussed. The 
therapist taught the couples basic communication skills (i.e., active listening) and conflict 
resolution behaviors to minimize any potential conflict that may have occurred. Participants 
were provided a brief overview on progressive muscle relaxation and were asked to briefly 
practice this technique in the session.
Couples were asked to identify a weekly Celebration Day activity to acknowledge 
successful non-smoking. The couple was also asked to develop shared rewarding activities 
to complete regularly and plans were developed for the upcoming week. In the final 
sessions, a relapse Prevention Plan was developed.
Standard Smoking Cessation Treatment (ST)—In the standard condition (ST), 
smoking cessation treatment was individually delivered and followed guidelines for 
smoking cessation (USDHHS, 2000). Sessions focused on learning behaviors and skills 
associated with quitting. Participants received self-help materials that included instructions 
on how to enlist social support (Orleans et al., 1991) consistent with standard practices used 
in community smoking cessation programs.
To match on time and attention, the ST condition contained an extended module on 
relaxation training. In a recent meta-analysis, relaxation training was not shown to be an 
active treatment component in smoking cessation and did not significantly improve 
treatment outcomes (Fiore, 2008). The relaxation module included a rationale for relaxation 
to manage stress while quitting and a therapist-guided progressive muscle relaxation practice 
during the session. In sessions 2–7, a shortened progressive muscle relaxation protocol was 
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used. The therapist inquired briefly as to the participants’ use of the techniques outside of 
the session but practice was not assigned.
Follow-up post-treatment—At the last treatment session, participants in both conditions 
were scheduled for follow-up interviews at 3- and 6-months post treatment, which were 
conducted with smokers at the study center and via phone for partners. All participants were 
contacted for follow-up assessment, regardless of degree of session attendance. Smokers and 
their partners were compensated for all treatment sessions and follow-ups.
Therapist Training—Therapists were required to read literature on BCT (O’Farrell & 
Fals Stewart, 2006) and to read the Smoking Cessation Clinical Guidelines (USDHHS, 
2000). Using BCT-S and ST therapist training manuals, therapists participated in weekly 
one-hour training sessions for two months prior to randomization. Training included an 
overview of BCT-S and ST treatment rationale and protocols, review of manuals and 
handouts, review of taped examples of sessions conducted by the PI for each session, and 
role-play exercises. In group training, therapists were required to role play each session 
protocol before participants were assigned to them. The PI and fellow therapists completed 
Adherence Checklists while each therapist role-played sessions.
Treatment Integrity—Manualized protocols for rating treatment integrity were used for 
both BCT-S and ST, adapted from the Raters Manual for Project Match Tape Rating Scale 
and the Yale Adherence and Competence Scale Guidelines (Carroll et al, 2000). In addition 
to live supervision (role-plays), all sessions were audiotaped (with participant informed 
consent) and rated by the PI (LaChance) and the research coordinator. Therapists were rated 
weekly and provided feedback on adherence to manual-specific active components, level of 
skill across treatments, appropriate structure and focus, and empathy and facilitation of the 
therapeutic alliance. To monitor treatment implementation, therapists were provided ratings 
of their adherence and competence. Therapists followed the Adherence Checklist, which 
outlined each of the critical content topics, during their session administration. The 
checklists were then reviewed by the research coordinator to ensure the total protocol 
content was covered in sessions. Therapist audiotapes were reviewed and rated by the PI and 
research coordinator on the frequency and extensiveness of therapist behaviors and the 
quality of treatment delivery (i.e., competence).
Measures
At the baseline interview, smokers and their partners each provided demographic and other 
background information including age, gender, marital status, race/ethnicity, education 
level, employment status, and income level. Smoking history included number of cigarettes 
smoked per day, number of years smoked, age of onset of regular smoking, and number of 
previous lifetime quit attempts. Nicotine dependence (in the smoker) was assessed with the 
6-item Fagerström Test for Nicotine Dependence (FTND; Heatherton, Kozlowski, Frecker, 
& Fagerström, 1991) with higher scores indicating greater nicotine dependence.
Smoking status—The primary outcome analyses were based on biochemically verified 7-
day point-prevalence abstinence (defined as self-reported no smoking for the 7-days prior to 
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the interview date) immediately post-treatment, and at 3- and 6-month follow ups (Hughes, 
et al., 2004). Self-reported abstinence was verified by expired air breath samples for carbon 
monoxide (CO), assessed with a Bedfont Scientific Smokelyzer® breath CO monitor, at 
baseline (both smoker and partner), at each treatment session (smoker only), and at each 
follow-up interview (smoker only). Detected values above the stated cutoff (> 8 ppm) were 
considered indicative of smoking (SRNT, Subcommittee on Biochemical Verification, 
2002). At 3- and 6-month follow ups (after completion of TNP), point-prevalence was 
verified by urinary cotinine analysis using the NicAlert Cotinine Test Strips (>3 indicated 
active smoking; Cooke et al., 2008) for stated abstinence of 7 days. Continuous abstinence 
was a secondary smoking outcome and was operationalized as the combination of both self-
reported abstinence and repeated biochemically-confirmed abstinence at every intermediate 
time point; from quit day to each subsequent treatment session, to post treatment, and follow 
ups. In cases where abstinence could not be biochemically verified, participants were 
characterized as smoking. This occurred in two cases at both post-treatment (PT) and 6 
months (M6); at PT, both cases were in the BCT-S condition, at 6M, one case was noted in 
each condition.
Partner support—The Partner Interaction Questionnaire (PIQ) was used to measure each 
smoker’s perceived smoking-specific support from his or her partner (Cohen et al., 1990; 
Mermelstein et al., 1983). This 20-item scale inquires about the support for quitting 
provided by a spouse or cohabitating partner and includes 10 positive and 10 negative 
behaviors a partner might perform. The ratio of positive to negative behaviors has been 
shown to be a better predictor of abstinence than positive or negative behaviors alone and 
higher ratios have been associated with abstinence (Cohen et al., 1990). Examining the PIQ 
ratio allowed us to compare partner support across treatment conditions.
The Dyadic Adjustment Scale is a 32-item scale to measure relationship adjustment (DAS; 
Spanier, 1976) and general relationship functioning with a range of scores from 0 to 151; a 
higher score indicates greater functioning. We used the DAS to examine whether 
interpersonal functioning was significantly related to abstinence at 6-months post-treatment.
Data Analysis
Descriptive statistics including means, proportions and standard deviations were calculated 
for all demographic and clinical characteristics. We used chi-square analyses and t-test 
statistics to examine between-groups differences in smokers’ and partners’ baseline 
characteristics. Chi-square tests were used to examine group differences in biochemically 
confirmed 7-day point prevalence abstinence rates at each time point. Independent t-tests 
were used to examine differences in continuous abstinence and differences in perceived 
partner support by treatment condition. Logistic regression was used to determine whether 
abstinence at six months was associated significantly with DAS score, treatment condition, 
or perceived smoking-specific partner support. Two-tailed tests and 95% significance levels 
were used to test for statistical significance. All statistical analyses were performed using 
Statistical Package for the Social Sciences version 21 (SPSS).
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RESULTS
Enrolled smokers were 67% (n =33) male, 87.8% White (n = 43), 4.1% Black (n=2), 2% 
American Indian/Alaska native (n=1), and 6.1% self-identified as multiracial (n=3). The 
mean age of the smokers was 42.8 (SD = 11.2) and 26.5% (n = 13) were college graduates. 
At baseline, participants smoked an average of 18.1 (SD = 5.2) cigarettes per day, had been 
smoking for an average of 25.8 (SD = 11.9) years, and had a mean FTND score of 4.9 (SD = 
1.6). Demographic and clinical characteristics of the 49 smokers (total sample and by 
treatment condition) are presented in Table 2. At baseline, there were no significant 
differences in the baseline and demographic characteristics of the smokers between 
treatment conditions. The partners of enrolled smokers had a mean age of 42.9 (SD = 11.6), 
were 79.6% White/Caucasian, 46.9% were employed full time, and 31 (63.3%) identified as 
never smoked.
Biochemically-verified cessation rates were 40.9%, 50% and 45% in the BCT-S arm and 
59.1%, 50%, and 55% in the ST arm, at end of treatment, 3-months, and 6-months, 
respectively. Biochemically confirmed 7-day point prevalence abstinence rates did not differ 
significantly between treatment arms at any time point (all p > .05; Table 3). Outcomes also 
did not differ significantly by treatment provider. Smokers in BCT had longer continuous 
abstinence (M = 60.7 days, SD 66.8) versus in ST (M = 50.3 days, SD 70.8) from quit date 
through the month six follow up, although the difference was not statistically significant, 
t(45.5) =.528, p= .60.
With regard to social support, smokers in the BCT-S condition had a similar PIQ ratio of 
perceived positive/negative partner support at immediate post-treatment (M = 2.5, SD .81) 
compared with smokers in the ST condition (M=2.3, SD .92), and this did not differ 
significantly (t(38) = .67, p= .51). Using regression analyses, verified abstinence at six 
months was not significantly associated with post-treatment DAS scores (B = -.003, 95% CI 
[.89, 1.1], p = .96), post-treatment perceived partner support (B = .178, 95% CI [.50, 2.82], p 
= .69), or treatment condition (B = -.85, 95% CI [.12, 1.54], p = .19).
Treatment satisfaction in both conditions was high (range 1 – 4), however there were no 
significant differences noted between smokers in the BCT-S (M= 3.55, SD .74) and ST 
(M=3.78, SD .55) treatment conditions, t(38) = −1.11, p = .27. The mean number of sessions 
attended out of seven was 6.12 (SD = 2.0) in BCT-S and 6.09 (SD = 1.9) in ST and did not 
differ significantly between treatment conditions (p = .96).
DISCUSSION
In this study, we developed and conducted a pilot randomized clinical trial of a BCT-based 
intervention for smoking, which was specifically designed to address limitations of previous 
studies and test the feasibility of BCT for smoking cessation. Although we were able to 
implement the intervention, we did not see significant differences in abstinence rates 
between the intervention and control groups. However, the biochemically-verified cessation 
rates were high in both treatment conditions, remaining at 45–55% through six months post-
treatment. This is noteworthy because although frequent attempts to quit are made, often 
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only a small percentage of smokers (approximately 6%) continue to abstain through 1 year 
(CDC, 2014). Studies that have combined transdermal nicotine therapy with a behavioral 
component often report low abstinence rates (18–26%) at follow-up (Fiore et al., 2008).
Our results do suggest that a BCT intervention for smoking cessation is both feasible and 
acceptable in smoking discordant couples. Notable features of our study results are excellent 
treatment session attendance and retention, high rates of treatment satisfaction, and overall 
high rates of confirmed smoking abstinence.
Smokers in the BCT-S condition did not perceive significantly higher positive support from 
their partners at immediate post-treatment compared with smokers in the ST condition. In a 
review by Park and colleagues (2012), they reported that only two studies of the eight 
reviewed demonstrated that partner support was increased after the partner support 
intervention, and four studies reported no difference in partner support between the 
intervention and control groups. Additionally, our results did not indicate that perceived 
partner support was significantly related with 6-month smoking abstinence. When BCT is 
used with patients with alcohol use disorders (AUD), it has been shown to be clearly more 
effective than individual treatment at increasing abstinence, and improving relationship 
functioning (O’Farrell & Schein, 2011; O’Farrell et al., 2010). Perhaps persons with AUD 
have substantially more relationship dysfunction and partner support issues related to their 
alcohol use compared with cigarette smokers, therefore substantiating the differences seen in 
BCT effectiveness with this population.
This study has several strengths. It is the first trial to incorporate and test BCT, an 
empirically-supported efficacious treatment for substance use disorders, for smoking 
cessation. It used a rigorous experimental design with a time-matched active control 
condition. Follow-up rates were high and did not differ by treatment condition. The study 
provided support for the feasibility and acceptability of BCT-S. Smokers in both groups had 
remarkable quit rates at immediate post-treatment, which were largely maintained through 
6-months post-treatment.
The study had some limitations. This was a pilot trial and therefore was not powered to 
demonstrate a statistically significant difference between treatment conditions. Kraemer et 
al. (2006) have suggested that perhaps significance may not be demonstrated in a pilot 
study, not because the results are clinically non-significant but potentially because the 
sample sizes are often too small to see statistically significant effects. However, pilot studies 
remain important in the research process to test the feasibility of new or innovative 
treatment protocols, to demonstrate the availability of participants for a treatment study, and 
to train research personnel in new study procedures (Kraemer et al, 2006). In our study, 
BCT was compared to an intensive active control condition (which included seven treatment 
sessions and 8 weeks of nicotine replace therapy). This raises the question as to whether 
involvement in the trial (or assessment alone) increased ST partners’ support for the 
smokers’ success. This may have contributed to the difficulty in detecting a significant 
effect related to the treatment condition. If BCT-S had been compared to “usual care”, the 
effect may have been more robust. Another factor to consider is that smokers in smoking-
discordant relationships may in general have higher success rates with cessation attempts 
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(Chandola et al., 2004). Traditionally, research on BCT for substance abuse disorders has 
excluded dual substance-using couples in order to utilize the non-substance-using partner’s 
support in modeling and reinforcing abstinence in the using partner (O’Farrell & Schein, 
2011). For this reason, we included only smoking-discordant couples in our study. Given 
that a recent study of BCT reported similar success rates when one or both partners had an 
AUD (Schumm, O’Farrell, & Andreas, 2012), that tobacco use is highly correlated within 
couples (Sutton, 1993), and that partner smoking is related to relapse (Kahn, Certain, & 
Whitaker, 2002), a BCT intervention for couples in which both partners smoke may be 
warranted. Future research should examine this question. Finally, this pilot study had a fairly 
homogeneous sample; our inclusion/exclusion criteria were specifically designed to achieve 
homogeneity and maximize power for treatment development testing (Rounsaville et al., 
2001). This may have contributed to our high cessation rates across both treatment 
conditions. We don’t know how BCT-S would perform in a more heterogeneous sample and 
subsequent larger scale trials should include more diverse samples.
In sum, this study does not provide evidence of the efficacy of BCT for smoking-discordant 
couples. Our restricted inclusion/exclusion criteria may have yielded a sample of smokers 
with a relatively high probability of smoking cessation success and with particularly 
supportive partners; that is, the relationships of participants may have been sufficiently 
healthy to preclude benefit from BCT above what could be obtained with an individually 
focused approach to smoking cessation. Given that BCT is feasible and acceptable for 
smoking cessation and that BCT has demonstrated efficacy in the treatment of other SUDs, 
further research may be warranted to determine whether BCT has efficacy in smokers with 
poorer cessation prognoses, including dual-smoking couples, those with dysfunctional 
relationships, and smokers with unsupportive partners.
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Figure 1. 
Participant flow diagram
CONSORT flowchart of eligibility, randomization, treatment, follow-up, and inclusion in 
analyses. BCT-S = behavioral couples treatment. ST = standard, individual smoking 
cessation treatment. MFU = month follow-up.
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Table 1
Session Content for Treatment Conditions
Behavioral Couples Therapy-
Smoking (BCT-S)
Individual Standard Treatment (ST)
Session 1–7 Content Session 1–7 Content
Review Commitment to Quitting Review Commitment to Quitting
Discussion of motivation to quit. Discussion of motivation to quit.
Couples complete I Quit Contract.
Discussion of Quitting Discussion of Quitting
Review past/current quit strategies with
couples. Review past/current quit strategies.
Effective Use of The Patch Effective Use of The Patch
Review instructions and provide patch. Review instructions and provide patch.
Couples learn and practice I Quit
Discussion. Anticipate High Risk Situations
Anticipate High Risk Situations
Review withdrawal, cravings, urges. Review withdrawal, cravings, urges.
Develop coping plan with smoker and
partner.
Develop coping plan.
Prepare for Quitting (Session 1) Prepare for Quitting (Session 1)
Couple exercise: Prepare a Non-
Smoking Home.
Encourage smoker to clean home.
Social Support Social Support
Couple exercise: Social Support
Strategies.
Encourage smoker to obtain support.
Training: Catch Your Partner Doing
Something Nice.
Relaxation Training Relaxation Training
Couples given brief overview on
progressive muscle relaxation.
Individuals taught extended progressive muscle
relaxation technique and a therapist-guided
practice.
Celebration day (Sessions 3–7) Reward day (Sessions 3–7)
Couples identify a weekly Celebration
Day activity.
Individuals are encouraged to celebrate their
successful quitting.
Relapse prevention Skill review. Relapse prevention Skill review.
Handouts Clearing the Air. Handouts Clearing the Air.
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Table 2
Baseline demographics (smokers) and comparison across treatment conditions.
Smokers
(N = 49)
BCT-SC
(N = 26)
IND
(N = 23)
P
Age, years (mean ± SD) 42.8 ± 11.2 42.4 ± 10.6 43.2 ± 11.9 .78
Male gender (N, %) 33 (67.3%) 18 (54.5%) 15 (45.5%) .76
Married (N,%) 38 (77.6%) 20 (52.6%) 18 (47.4%) .91
Race, White/Caucasian (n, %) 43 (87.8%) 24 (48.9) 19 (38.8)
Education (n, %)
  Some high school HS graduate 2 (4.1) 6 (12.2) 9 (18.4) .85
  HS graduate 6 (12.2) 20 (40.8) 14 (28.5)
  GED/Some college 23 (47.0)
  Tech/bus school 5 (10.2)
  College graduate 11 (22.4)
  Some graduate school 2 (4.1)
Employment (n, %) 29 (59.2%) 19 (38.8%) 15 (30.6) .68
  Full time
Household Income (n, %) 3 (6.1) .58
  Less than $29,000 5 (10.2%) 2 (4.0) 20 (40.8)
  $30,000 - $59,000 20 (40.8%) 10 (20.4) 14 (28.5)
  $60,000 – 89,000 14 (28.5%) 7 (14.2) 10 (20.4)
  More than $90,00 10 (20.4) 7 (14.2)
Smoking history variables (mean
±SD)
  Cigs per day 18.1 ± 5.2 17.9 (5.5) 18.4 (4.8) .72
  Number of years smoked 25.8 ± 11.9 25.2 (10.9) 26.5 (13.2) .72
  Age started daily cig smoking 17.2 ± 3.9 13.8 (5.3) 15.2 (4.3) .30
  Nicotine dependence (FTND) 4.9 ± 1.6 5.9 (1.3) 5.7 (1.6) .52
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Table 3
Outcomes at follow-up Biochemically-verified 7-day point prevalence abstinence (N, %)
Intervention
(BCT)
Standard
treatment
(IND)
p value
Post-treatment (N = 49) 9 (40.9%) 13 (59.1%) .12
3 months (N = 49) 10 (50%) 10 (50%) .72
6 months (N = 49) 9 (45%) 11 (55%) .35
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